Teva Pharmaceutical Industries acquired Hungary's Biogal Gyogyszergyar in 1995, expanding its generic pharmaceutical manufacturing footprint into Eastern Europe in a post-privatization acquisition. The deal strengthened Teva's European generics portfolio and manufacturing base.